Patients diagnosed with type 2 diabetes may have a higher risk of developing cancer, a new study has suggested. The study, ...

By Ernie Mundell HealthDay ReporterTUESDAY, Sept. 29, 2026 (HealthDay News) — A diagnosis of type 2 diabetes at a young age ...

Signs of type 2 diabetes can be detected in just a few seconds from the way someone talks, new research being presented at ...

Eli Lilly’s highly anticipated GLP-1 drug retatrutide helped people with Type 2 diabetes lose up to 60 pounds, or about 23% of their body weight, according to late-stage trial results published ...

The FDA has approved a once-weekly basal insulin to control glucose levels for adults with type 2 diabetes, Eli Lilly ...

Within five years of their diagnosis, patients with type 2 diabetes have a 33% increased risk of dying or developing kidney ...

The FDA has granted 510(k) clearance for an insulin titration algorithm that uses continuous glucose monitoring and insulin ...

Adults with type 2 diabetes on semaglutide injection 1 mg, whose dose was increased to 2 mg, were associated with a ...

The risk of developing chronic kidney disease (CKD) or heart failure (HF), or dying, following a type 2 diabetes (T2D) ...

MODI is the first FDA-cleared solution to use glucose-monitoring data to automatically optimize insulin dosing for people with type 2 diabetes across both basal-only and multiple daily injection ...

The area in which someone lives strongly influences their risk of developing type 2 diabetes, new research from Canada being ...

The FDA approved Onswik, a once-weekly basal insulin for adults with type 2 diabetes. Here's how it works, who it's for and ...